Yasuyoshi Miyata Selected Research

Prostaglandins

10/2021	Oral administration of E-type prostanoid (EP) 1 receptor antagonist suppresses carcinogenesis and development of prostate cancer via upregulation of apoptosis in an animal model.
9/2021	Pathological Roles of Prostaglandin E2-specific E-type Prostanoid Receptors in Hormone-sensitive and Castration-resistant Prostate Cancer.
2/2013	[Expression and function of E prostanoid receptors in urological cancer].
1/2013	Tumor-associated stromal cells expressing E-prostanoid 2 or 3 receptors in prostate cancer: correlation with tumor aggressiveness and outcome by angiogenesis and lymphangiogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuyoshi Miyata Research Topics

Disease

78	Neoplasms (Cancer) 02/2023 - 09/2002
30	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 03/2003
27	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 02/2003
23	Urinary Bladder Neoplasms (Bladder Cancer) 08/2021 - 02/2006
18	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2006
8	Overactive Urinary Bladder (Overactive Bladder) 07/2022 - 07/2016
6	Lower Urinary Tract Symptoms 03/2022 - 07/2016
6	Non-Muscle Invasive Bladder Neoplasms 01/2022 - 01/2015
6	Carcinogenesis 10/2021 - 01/2017
4	Disease Progression 01/2022 - 08/2014
4	Urologic Neoplasms (Urological Cancer) 01/2018 - 02/2013
4	Carcinoma (Carcinomatosis) 08/2012 - 06/2005
3	Chronic Kidney Failure (Chronic Renal Failure) 12/2022 - 07/2019
3	Spinal Cord Diseases 07/2021 - 01/2018
3	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 07/2021 - 01/2018
3	Fatigue 10/2020 - 10/2015
3	Nocturia 04/2019 - 01/2017
3	Pain (Aches) 10/2015 - 11/2005
3	Transitional Cell Carcinoma 06/2006 - 03/2004
2	Hypertension (High Blood Pressure) 03/2022 - 12/2015
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2022 - 01/2021
2	Erectile Dysfunction 01/2022 - 07/2004
2	Renal Insufficiency (Renal Failure) 12/2021 - 01/2013
2	Atherosclerosis 12/2021 - 08/2005
2	Hypoxia (Hypoxemia) 08/2021 - 03/2007
2	Anorexia 10/2020 - 12/2018
2	Autoimmune Diseases (Autoimmune Disease) 10/2018 - 01/2017
2	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 06/2013
2	Peritonitis 01/2014 - 09/2006
2	Fibrosis (Cirrhosis) 01/2013 - 12/2005

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2002
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2020 - 03/2003
10	Matrix Metalloproteinases (MMPs)IBA 05/2019 - 05/2003
7	royal jellyIBA 12/2021 - 10/2018
7	Cisplatin (Platino)FDA LinkGeneric 12/2020 - 06/2011
7	Gemcitabine FDA Link 07/2020 - 06/2011
6	Dinoprostone (PGE2)FDA Link 10/2021 - 01/2005
6	AntigensIBA 10/2018 - 01/2016
6	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2017 - 05/2003
5	mirabegronIBA 07/2022 - 07/2016
5	Biomarkers (Surrogate Marker)IBA 08/2021 - 11/2007
5	PolyphenolsIBA 01/2021 - 06/2010
5	Paclitaxel (Taxol)FDA LinkGeneric 11/2019 - 12/2011
5	TeaIBA 01/2019 - 06/2010
4	ProstaglandinsIBA 10/2021 - 01/2013
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2020 - 05/2003
4	Vascular Endothelial Growth FactorsIBA 01/2017 - 02/2006
4	Formaldehyde (Formol)FDA Link 12/2014 - 01/2005
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2011 - 03/2003
4	Proto-Oncogene Proteins c-metIBA 04/2009 - 03/2003
3	Sunitinib (Sutent)FDA Link 01/2022 - 06/2018
3	Macrophage Colony-Stimulating FactorIBA 12/2021 - 08/2005
3	stage-specific embryonic antigen-4IBA 07/2021 - 10/2019
3	ThrombospondinsIBA 05/2021 - 05/2003
3	SaltsIBA 01/2021 - 01/2017
3	Tyrosine Kinase InhibitorsIBA 11/2020 - 12/2018
3	Heme Oxygenase-1IBA 07/2020 - 12/2014
3	4N1K peptideIBA 05/2019 - 05/2003
3	AntibodiesIBA 01/2017 - 08/2006
3	Matrix Metalloproteinase 2 (Gelatinase A)IBA 04/2009 - 05/2003
3	Phosphotransferases (Kinase)IBA 01/2009 - 03/2003
2	CalciumIBA 03/2022 - 08/2005
2	Immune Checkpoint InhibitorsIBA 01/2022 - 04/2020
2	Malondialdehyde (Propanedial)IBA 12/2021 - 08/2021
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2021 - 10/2018
2	8-Hydroxy-2'-DeoxyguanosineIBA 12/2021 - 08/2021
2	Hormones (Hormone)IBA 09/2021 - 01/2016
2	Antigen-Antibody Complex (Immune Complex)IBA 08/2021 - 01/2017
2	Ceruloplasmin (Ferroxidase)IBA 08/2021 - 07/2021
2	Androgen Receptors (Androgen Receptor)IBA 07/2021 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2020 - 10/2017
2	AntioxidantsIBA 05/2019 - 10/2018
2	Thrombospondin 1IBA 05/2019 - 06/2013
2	Small Interfering RNA (siRNA)IBA 01/2018 - 01/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 06/2013
2	CreatinineIBA 01/2018 - 01/2014
2	AndrogensIBA 04/2017 - 01/2017
2	Vascular Endothelial Growth Factor CIBA 01/2017 - 02/2006
2	Guanosine Triphosphate (GTP)IBA 01/2017 - 06/2010
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 03/2015 - 08/2005
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 12/2014 - 01/2009
2	Vascular Endothelial Growth Factor DIBA 12/2014 - 02/2006
2	NitrosaminesIBA 01/2013 - 06/2010
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2011 - 02/2009
2	Matrix Metalloproteinase 7 (Matrilysin)IBA 11/2009 - 12/2006
2	Tyrosine (L-Tyrosine)FDA Link 04/2009 - 08/2006
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2008 - 07/2006
2	Mitogen-Activated Protein KinasesIBA 02/2008 - 07/2006

Therapy/Procedure

36	Therapeutics 01/2022 - 02/2003
9	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 06/2004
5	Nephrectomy 12/2022 - 01/2009
5	Castration 09/2021 - 01/2016
5	Drug Therapy (Chemotherapy) 04/2020 - 04/2006
4	Molecular Targeted Therapy 12/2020 - 08/2014
4	Aftercare (After-Treatment) 01/2018 - 09/2012
3	Renal Dialysis (Hemodialysis) 12/2021 - 07/2004
3	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2021 - 07/2019
2	Kidney Transplantation 02/2023 - 07/2019
2	Radiotherapy 08/2014 - 04/2006
2	Combination Drug Therapy (Combination Chemotherapy) 12/2011 - 06/2011